Screening for liver cancer in high-risk patients
Part of Cancer, Digestive system, Infections clinical trials.
This trial is testing a routine screening program for liver cancer (hepatocellular carcinoma) in people who are at higher risk of developing it. The goal is to catch cancer early, when treatment works best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have liver cirrhosis (scarring of the liver) from any cause.
- You have chronic hepatitis B with moderate or high risk for liver cancer.
- You have advanced liver fibrosis (stage 3 or higher) or a liver condition called MASLD with additional risk factors.
- You are already a patient in the Rede D'Or health network hepatology clinics.
- You are eligible for routine liver cancer screening with ultrasound and blood tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new way to screen for liver cancer in people with cirrhosis or chronic hepatitis B. It aims to find cancer earlier so it can be treated more effectively.
This trial tests a new blood test to help detect liver cancer (HCC) or confirm it’s not present in people with cirrhosis who are being monitored. It may help improve how doctors screen for liver cancer and decide who needs further imaging or treatment.
This study follows people with cirrhosis to see how best to detect liver cancer early. If you qualify, you may receive regular monitoring that could help find liver cancer sooner, when treatment is more likely to work.
This study tests whether adding a simple blood test (GAAD score) to a routine liver ultrasound can find early-stage liver cancer sooner in people with chronic liver conditions. It aims to improve detection in Asian populations at risk.
This study looks at how well doctors can detect small, early liver cancer and then follow how it changes over time. It may help your care team choose the best next steps based on earlier, clearer detection.
This trial aims to discover new immune system targets on liver cancer cells and other tumors to develop better immunotherapies. Researchers will analyze tumor samples to find these targets, which could lead to more effective treatments.
Hear when a new Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.